InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Ali-Jackson Kamil, Directeur Juridique. Director active across 3 companies, notably Aclaris Therapeutics, Inc.. In total, 15 reports have been published. Total volume traded: €508k. The latest transaction was disclosed on 20 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations15 total
018,750 shares0
Common Stock
SEC:0001140361-22-020303:0·
3,875 shares
Common Stock
SEC:0001209191-22-001712·
3,875 shares
Common Stock
SEC:0001209191-22-001712:0·
07,500 shares0
Common Stock
SEC:0001209191-21-066084·
07,500 shares0
Common Stock
SEC:0001209191-21-066084:0·
€82,45511,764 shares@ €7.0091100.0% of flow
Common Stock
SEC:0001140361-21-021497·
Ideal exit: 12 Mar 2022 (T+270)
€82,45511,764 shares@ €7.00910.20% mcap50.0% of flow
Common Stock
SEC:0001140361-21-021497:0·
Ideal exit: 12 Mar 2022 (T+270)
€171,7809,492 shares@ €18.09730.027% mcap56.5% of flow
Common Stock
SEC:0001209191-21-038442·
€171,7809,492 shares@ €18.09730.027% mcap23.2% of flow
Common Stock
SEC:0001209191-21-038442:0·
33,189 shares
Common Stock
SEC:0001209191-21-037482·
33,189 shares
Common Stock
SEC:0001209191-21-037482:0·
€132,49315,000 shares@ €8.83290.021% mcap43.5% of flow
Common Stock
SEC:0001209191-21-031038·
€132,49315,000 shares@ €8.83290.021% mcap17.9% of flow
Common Stock
SEC:0001209191-21-031038:0·
15,000 shares
Common Stock
SEC:0001209191-21-030491·
€132,57315,000 shares@ €8.83820.021% mcap17.9% of flow
Common Stock
SEC:0001209191-21-030491:0·
15 of 15 declarations
About Ali-Jackson Kamil
Ali-Jackson Kamil is the Legal Director at Aclaris Therapeutics, Inc. He oversees the legal affairs of the company.
